NextPlat Corp (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology solutions, announced the opening of a new PharmcoRx community pharmacy in Jacksonville, Florida. This expansion increases NextPlat's healthcare footprint in the state and positions the company to capture growing demand for integrated pharmacy services.
The new pharmacy, located across from HCA Florida Memorial Hospital, offers prescription fulfillment, medication management, same-day delivery, specialty pharmacy services, and patient support. Beyond traditional retail services, the location provides higher-margin contracted services for healthcare providers and institutions, including participants in the federal 340B drug pricing program, long-term care facilities, and government agencies. These services are critical for underserved populations, and the strategic location near a major hospital enhances patient access and care coordination.
PharmcoRx currently operates a network of six retail pharmacies across Florida. The Jacksonville opening is part of NextPlat's broader strategy to combine retail pharmacy operations with contracted healthcare services. The company is actively pursuing additional locations and selective acquisitions to serve underserved communities, which could drive revenue growth and improve patient outcomes. For investors, this move signals NextPlat's commitment to scaling its healthcare division, which may lead to increased market share and diversified income streams.
The expansion also aligns with NextPlat's focus on e-Commerce and technology solutions. Through its subsidiary, Progressive Care, the company offers pharmacy and healthcare data management services in the United States, complementing its global e-Commerce communications division that provides voice, data, tracking, and IoT products. By integrating retail and contracted services, NextPlat aims to optimize operations and enhance profitability.
Investors can find more details in the full press release available at https://ibn.fm/sAbp7. The latest news and updates relating to NXPL are available in the company's newsroom at https://ibn.fm/NXPL.
The announcement was distributed through BioMedWire, a specialized communications platform focused on the biotechnology, biomedical sciences, and life sciences sectors. BioMedWire is part of the Dynamic Brand Portfolio at IBN, which provides wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and tailored corporate communications solutions. This broad reach ensures that NextPlat's news is widely disseminated to investors and stakeholders.
For more information about BioMedWire, visit www.BioMedWire.com. The terms of use and disclaimers applicable to all content provided by BioMedWire are available at https://www.BioMedWire.com/Disclaimer.
